Pharmaxis has key drivers in place for short and long term value creation
15th
May 18
Release Date: 15/05/2018 11:30am
Pharmaxis chief executive Gary Phillips speaks to Proactive Investors about the pharmaceutical research company’s business model and value drivers, and provides some context about the sector, which is seeing a lot of headline-grabbing merger and acquisition activity.Pharmaxis CEO Gary Phillips discusses the Company’s drug discovery team. (Watch the video here)
Categories: Video Content